Appropriate use of complementary and alternative medicine approaches in gynecologic cancers

Dana M. Chase, Steven J. Gibson, Daniele A. Sumner, Jennifer W. Bea, David S. Alberts

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Gynecologic cancer patients frequently desire alternative and/or complementary interventions or medicines to aid in relief of both cancer-related and treatment-related side effects. Furthermore, women also seek treatment to aid in superior outcomes and cure rates. Unfortunately, evidence suggests that the use of complementary and/or alternative medicine (CAM) is underreported or not discussed with physicians providing cancer care. In gynecologic cancer literature, there is a lack of scientific evidence either supporting or negating CAM. Because of the lack of information available, health care providers do not have good information regarding safety, efficacy, and dose of CAM. This leads to miscommunication or absence of communication between providers and patients. Because patients do use CAM to improve quality of life (QOL) during and after treatment, it would be educational for providers to know the specific QOL deficits among patients that require attention. Thus, with the ultimate goal of improving QOL for gynecologic cancer patients, providers should be pushed to investigate CAM and determine an honest support or rejection of these therapies.

Original languageEnglish (US)
Pages (from-to)14-26
Number of pages13
JournalCurrent Treatment Options in Oncology
Issue number1
StatePublished - Mar 2014


  • Alternative medicine
  • Cervical cancer
  • Complementary medicine
  • Gynecologic cancer
  • Ovarian cancer

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)


Dive into the research topics of 'Appropriate use of complementary and alternative medicine approaches in gynecologic cancers'. Together they form a unique fingerprint.

Cite this